A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...
Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...
An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
14d
Boing Boing on MSNFDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
14d
Tampa Free Press on MSNHow Ketamine Therapy Helps With Depression And PTSDExploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting a significant number of individuals globally. Traditional therapies might ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental health conditions. However, they may cover the FDA-approved nasal spray, ...
If you're considering getting Starlink satellite internet, check out this simplified breakdown of the different pricing tiers, subscription costs, and equipment fees. My title is Senior Features ...
TARA Mind launched its Mental Health Savings Calculator, a tool to help employers combat the rising costs of untreated mental health conditions.
Netflix is starting off the new year with another subscription price hike. The latest price change, Netflix's first in the U.S. since October 2023, comes after the company reported adding a record ...
to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday. The ketamine-derived drug was first approved in 2019 to be used in combination ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results